FibroGen Inc
FGEN
Market Cap$123.35M
Close$
$3.46
188.7% upside
Current Fair Value
188.7% upsideUndervalued by 188.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $123.35 Million |
|---|---|
| Enterprise Value | $17.96 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.44 |
| Beta | 3.27 |
| Outstanding Shares | 99,474,398 |
| Avg 30 Day Volume | 3,047,637 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.51 |
|---|---|
| PEG | 0.9 |
| Price to Sales | 1.2 |
| Price to Book Ratio | -0.4 |
| Enterprise Value to Revenue | 0.11 |
| Enterprise Value to EBIT | -0.08 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 4.02 |
| Debt to Equity | -0.32 |
Revenue Sources
No data
ESG Score
No data
About FibroGen Inc
CEO: Enrique Conterno